Exisulind
- Level
- Commodity
- Parent
- 51386100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51386101This classification denotes a cyclooxygenase inhibitor with the molecular formula C20H17FO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K619IIG2R9, chemically known as 1h-indene-3-acetic acid, 5-fluoro-2-methy l-1-((4-(methylsulfonyl)phenyl)methylene)- but generally known as exisulind, which bears US NIH Compound Identifier 5472495. The term EXISULIND is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule exisulind under HS 29309085 and SITC 51549. As of Q4 2014, EXISULIND remains the US FDA Preferred Term for this commodity. Exisulind bears US NLM identifiers UMLS ID C0075616 and NCI Concept Code C1239. SMILES: CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O.
Same parent
Under 51386100 · 2Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.